NextCure, Inc. (NXTC) Financials
NXTC Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 38.0 million | 11.3 million |
| Dec. 31, 2025 | 50.2 million | 15.2 million |
| Sept. 30, 2025 | 39.6 million | 16.0 million |
| June 30, 2025 | 47.7 million | 16.0 million |
NXTC Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -13.4 million | 344000 |
| Dec. 31, 2025 | -7.6 million | 435000 |
| Sept. 30, 2025 | -6.3 million | 600000 |
| June 30, 2025 | -22.7 million | 588000 |
NXTC Net Income
No data available :(
NXTC Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 29.7 million | 3.9 million | - |
| Dec. 31, 2025 | 41.8 million | - | 4.1 million |
| Sept. 30, 2025 | 29.1 million | 4.4 million | 4.4 million |
| June 30, 2025 | 35.3 million | - | 4.7 million |
NXTC Shares Outstanding
NXTC Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 6.8 million | 3.3 million | - |
| Dec. 31, 2025 | - | 6.8 million | 3.0 million | - |
| Sept. 30, 2025 | - | 6.1 million | 2.8 million | - |
| June 30, 2025 | - | 24.1 million | 3.2 million | - |
NXTC Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 283000 |
| Dec. 31, 2025 | - | 365000 |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | - | 633000 |
NXTC
Price: $2.02
52 week price:
Earnings Per Share: -16.82 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 224200
Market Capitalization: 8.4 million